Biodexa Pharmaceuticals (BDRX) Amortization - Intangibles (2014 - 2020)
Biodexa Pharmaceuticals (BDRX) reported Amortization - Intangibles of -$16.3 million for Q4 2020, down 11.9% sequentially from -$14.6 million in Q3 2020.
Biodexa Pharmaceuticals (BDRX) Amortization - Intangibles (2014 - 2020) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 3 years of Amortization - Intangibles data on file, last reported at -$16.3 million in Q4 2020.
- For the quarter ending Q4 2020, Amortization - Intangibles changed N/A year-over-year to -$16.3 million; the trailing twelve-month figure through Dec 2020 stood at -$51.1 million (changed N/A YoY), and the FY2020 full-year result was -$15.9 million, changed N/A from the prior year.
- Amortization - Intangibles declined to -$16.3 million in Q4 2020, from -$14.6 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of -$14.6 million in Q3 2020 to a low of -$16.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -16.33 Mn |
| Sep 10, 2020 | -14.60 Mn |
| Dec 31, 2015 | -17.32 Mn |
| Dec 31, 2014 | -2.85 Mn |